Updated
Reviewed
Aug. 01, 2019
Appendix B: Panel Roster and Financial Disclosures
Toxoplasma gondii
| Member | Financial Disclosure | ||
|---|---|---|---|
| Company | Relationship | ||
| Boyd, Sarita | Food and Drug Administration | None | N/A |
| Chow, Felicia | University of California, San Francisco | None | N/A |
| Kovacs, Joe* | National Institutes of Health | Matinas BioPharma | Research Support |
| Merck | Research Support | ||
| Kuruppu, Janaki | National Institutes of Health | None | N/A |
| Lai, Leon | Washington Hospital Center | None | N/A |
| Miro, Jose M. | Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain | None | N/A |
| Podzamczer, Daniel | Hospital Universitari de Bellvitge, Barcelona, Spain | None | N/A |
| * Group lead Note: Members were asked to disclose all relationships from 12 months prior to the update date. The period of reporting was from August 1, 2018, through August 1, 2019. |
|||
Download Guidelines
- Section OnlyPDF (337.79 KB)
- Full GuidelinePDF (3.78 MB)
- Tables OnlyPDF (481.21 KB)